Selected article for: "clinical practice and gender age"
Author: Ye, Cong; Cai, Shaozhe; Shen, Guifen; Guan, Hanxiong; Zhou, Liling; Hu, Yangyang; Tu, Wei; Chen, Yu; Yu, Yikai; Wu, Xuefen; Chen, Yuxue; Zhong, Jixin; Dong, Lingli
Title: Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
  • Cord-id: yczpj9ng
  • Document date: 2020_5_22
    • ID: yczpj9ng
    Snippet: OBJECTIVE: The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-19) have not been reported. This study aimed to describe the clinical features of COVID-19 in rheumatic patients and provide information for handling this situation in clinical practice. METHODS: This is a retrospective case series study. Deidentified data, including gender, age, laboratory and radiological results, symptoms, signs, and medication history, were collected from 2326 patients diagnosed with
    Document: OBJECTIVE: The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-19) have not been reported. This study aimed to describe the clinical features of COVID-19 in rheumatic patients and provide information for handling this situation in clinical practice. METHODS: This is a retrospective case series study. Deidentified data, including gender, age, laboratory and radiological results, symptoms, signs, and medication history, were collected from 2326 patients diagnosed with COVID-19, including 21 cases in combination with rheumatic disease, in Tongji Hospital between 13 January and 15 March 2020. RESULTS: Length of hospital stay and mortality rate were similar between rheumatic and non-rheumatic groups, while the presence of respiratory failure was more common in rheumatic cases (38% vs 10%, p<0.001). Symptoms of fever, fatigue and diarrhoea were seen in 76%, 43% and 23% of patients, respectively. There were four rheumatic patients who experienced a flare of rheumatic disease during hospital stay, with symptoms of muscle aches, back pain, joint pain or rash. While lymphocytopaenia was seen in 57% of rheumatic patients, only one patient (5%) presented with leucopenia in rheumatic cases. Rheumatic patients presented with similar radiological features of ground-glass opacity and consolidation. Patients with pre-existing interstitial lung disease showed massive fibrous stripes and crazy-paving signs at an early stage. Five rheumatic cases used hydroxychloroquine before the diagnosis of COVID-19 and none progressed to critically ill stage. CONCLUSIONS: Respiratory failure was more common in rheumatic patients infected with COVID-19. Differential diagnosis between COVID-19 and a flare of rheumatic disease should be considered. TRIAL REGISTRATION NUMBER: ChiCTR2000030795.

    Search related documents:
    Co phrase search for related documents
    • acid detection kit and lung disease: 1
    • acid detection kit and lymphocyte count: 1
    • active status and admission discharge: 1
    • active status and lung damage: 1
    • active status and lupus erythematosus: 1
    • active status and lymphocyte count: 1, 2
    • admission discharge and long term treatment: 1, 2, 3
    • admission discharge and lung damage: 1, 2, 3
    • admission discharge and lung disease: 1, 2, 3, 4, 5
    • admission discharge and lung involvement: 1, 2, 3, 4, 5
    • admission discharge and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • admission discharge time and long term treatment: 1
    • admission discharge time and lymphocyte count: 1, 2, 3, 4, 5
    • liver dysfunction and lung damage: 1, 2
    • liver dysfunction and lung disease: 1, 2, 3, 4, 5, 6
    • liver dysfunction and lung involvement: 1
    • liver dysfunction and lymphocyte count: 1, 2, 3
    • long term treatment and lung damage: 1, 2, 3
    • long term treatment and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9